Response Genetics Inc
Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gast… Read more
Response Genetics Inc (RGDXQ) - Total Assets
Latest total assets as of March 2015: $10.78 Million USD
Based on the latest financial reports, Response Genetics Inc (RGDXQ) holds total assets worth $10.78 Million USD as of March 2015.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Response Genetics Inc - Total Assets Trend (2005–2015)
This chart illustrates how Response Genetics Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Response Genetics Inc - Asset Composition Analysis
Current Asset Composition (December 2015)
Response Genetics Inc's total assets of $10.78 Million consist of 57.7% current assets and 42.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 39.8% |
| Accounts Receivable | $6.62 Million | 13.5% |
| Inventory | $133.00K | 0.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.73 Million | 3.5% |
| Goodwill | $12.03 Million | 24.6% |
Asset Composition Trend (2005–2015)
This chart illustrates how Response Genetics Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Response Genetics Inc's current assets represent 57.7% of total assets in 2015, a decrease from 85.2% in 2005.
- Cash Position: Cash and equivalents constituted 39.8% of total assets in 2015, down from 62.9% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 27.0% of total assets, an increase from 0.0% in 2005.
- Asset Diversification: The largest asset category is goodwill at 24.6% of total assets.
Response Genetics Inc Competitors by Total Assets
Key competitors of Response Genetics Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Response Genetics Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Response Genetics Inc generates 0.37x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Response Genetics Inc is currently not profitable relative to its asset base.
Response Genetics Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.80 | 1.87 | 2.05 |
| Quick Ratio | 1.80 | 1.87 | 2.05 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.88 Million | $ 5.51 Million | $ 5.76 Million |
Response Genetics Inc - Advanced Valuation Insights
This section examines the relationship between Response Genetics Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.00 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 263.6% |
| Total Assets | $48.88 Million |
| Market Capitalization | $0.99 USD |
Valuation Analysis
Below Book Valuation: The market values Response Genetics Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Response Genetics Inc's assets grew by 263.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Response Genetics Inc (2005–2015)
The table below shows the annual total assets of Response Genetics Inc from 2005 to 2015.
| Year | Total Assets | Change |
|---|---|---|
| 2015-12-31 | $48.88 Million | +263.58% |
| 2014-12-31 | $13.45 Million | -25.55% |
| 2013-12-31 | $18.06 Million | +8.86% |
| 2012-12-31 | $16.59 Million | +111.31% |
| 2011-12-31 | $7.85 Million | -25.95% |
| 2010-12-31 | $10.60 Million | -1.77% |
| 2009-12-31 | $10.79 Million | -20.34% |
| 2008-12-31 | $13.55 Million | -44.51% |
| 2007-12-31 | $24.41 Million | +195.58% |
| 2006-12-31 | $8.26 Million | +97.30% |
| 2005-12-31 | $4.19 Million | -- |